Jennifer O’Neil

Company: Xilio Therapeutics Inc.

Job title: Vice President Translational Sciences

Seminars:

Emerging Learnings From Pre-Clinical Combinations of Tumor-Activated Cytokines With Other Immune-oncology Agents 11:00 am

Revealing the scientific rationale for using cytokines in combination Addressing challenges in combining systemically active cytokines Exploring Pre-clinical data supporting use of Xilio’s tumor-activated cytokines in combination with other IO agentsRead more

day: Conference Day Two